John Marshall, MD, discusses the realities of metastatic colorectal cancer management and therapy options to consider outside of chemotherapy—regorafenib, in particular.
September 13th 2021
John Marshall, MD, provides an overview of the colorectal cancer landscape.
Dr Marshall explains the different frontline treatment options for metastatic colorectal cancer, as well as maintenance therapy.
A gastrointestinal cancers expert describes monitoring strategies for progression of metastatic colorectal cancer.
Dr Marshall discusses the impact regorafenib has had in the treatment of metastatic colorectal cancer and describes data from the CORRECT and ReDOS clinical trials.
John Marshall, MD, speaks on regorafenib sequencing and relays his thoughts on the future of treatment for metastatic colorectal cancer.